Waldencast plc (NASDAQ:WALD) Short Interest Down 25.2% in June

Waldencast plc (NASDAQ:WALD) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 385,000 shares, a decrease of 25.2% from the May 31st total of 514,400 shares. Based on an average daily volume of 92,700 shares, the short-interest ratio is presently 4.2 days. Approximately 1.7% of the company’s shares are short sold.

Waldencast Price Performance

Shares of NASDAQ:WALD opened at $3.59 on Monday. The firm’s 50 day simple moving average is $4.48 and its 200-day simple moving average is $6.73. The company has a quick ratio of 0.82, a current ratio of 1.71 and a debt-to-equity ratio of 0.22. Waldencast has a one year low of $3.54 and a one year high of $12.00.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on WALD. Telsey Advisory Group reissued an “outperform” rating and issued a $8.00 price objective on shares of Waldencast in a research note on Tuesday, May 21st. DA Davidson cut their price objective on Waldencast from $15.50 to $6.50 and set a “buy” rating on the stock in a research report on Tuesday, May 28th.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Barclays PLC grew its position in shares of Waldencast by 75.3% during the 3rd quarter. Barclays PLC now owns 7,177 shares of the company’s stock worth $67,000 after buying an additional 3,084 shares in the last quarter. Catalina Capital Group LLC bought a new position in Waldencast during the 1st quarter worth about $73,000. Norden Group LLC purchased a new position in Waldencast during the 1st quarter valued at about $92,000. Bleakley Financial Group LLC bought a new stake in shares of Waldencast in the 1st quarter valued at about $142,000. Finally, Simplicity Wealth LLC purchased a new stake in shares of Waldencast in the 1st quarter worth approximately $142,000. 41.97% of the stock is currently owned by hedge funds and other institutional investors.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.